异醇衍生物作为多目标药物:对皮肤癌细胞具有杀病毒,抗菌和抗增殖作用
Izabela Jęśkowiak-Kossakowska1, Paulina Nowotarska2, Elżbieta Gębarowska3
1Wroclaw Medical University, Faculty of Medicine, Department of Pharmacology, Mikulicza-Radeckiego 2, Wrocław, 50-345, Poland. izabela.jeskowiak-kossakowska@umw.edu.pl.
Pharmacological reports : PR
|March 4, 2026
概括
新的伊索克萨衍生物显示为治疗皮肤疾病的多功能疗法具有前途. 化合物MO3针对耐药细菌,MO7对抗腺病毒感染,MO10对抗HSV-1和黑色素瘤.
科学领域:
- 皮肤病学 皮肤病学
- 药用化学 医学化学
- 传染性疾病 传染性疾病
背景情况:
- 炎症性皮肤疾病由于微生物感染和癌症风险而带来挑战.
- 抗菌素耐药性和缺乏对人类腺病毒 (HAdV) 等病原体的治疗方法,需要新的治疗方法.
研究的目的:
- 为了识别具有联合抗菌,抗病毒和抗癌特性的异醇衍生物,用于皮肤病学.
- 开发新型疗法,解决治疗耐药性感染和病毒性疾病的未满足需求.
主要方法:
- 使用阿加扩散,定量悬浮试验,MTT,Rho-123,DCF-DA,Griess测试对异醇衍生物的查.
- 针对卡斯帕斯-3,IL-6,TNF-α,COX和基于微芯片的亡检测的ELISA.
- 在 silico 和 in vitro 对生物活性和毒性的评估.
主要成果:
- 化合物MO3表现出强大的抗菌活性,可对抗黄金葡萄球菌和S. pseudintermedius.
- MO7对AdV-5具有很高的杀菌效果,而MO10对HSV-1具有很高的杀菌效果.
- MO10在黑色素瘤中表现出抗癌作用,包括NO介导的亡和与多克索鲁比辛的协同作用.
结论:
- 伊索克萨衍生物MO3,MO7和MO10分别是治疗耐药细菌感染,腺病毒感染和HSV-1的有希望的候选者.
- MO10 作为病毒感染的双重作用剂和黑色素瘤化疗的辅助剂.
- 这项研究强调了异醇在开发多功能皮肤治疗药物的潜力.
更多相关视频
06:34Synthesis of Antiviral Tetrahydrocarbazole Derivatives by Photochemical and Acid-catalyzed C-H Functionalization via Intermediate Peroxides CHIPS
Published on: June 20, 2014
14.5K
12:42Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo
Published on: January 7, 2019
10.3K
相关概念视频
01:30Skin Cancer
6.4K
Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
6.4K
02:49Cancer Therapies
10.5K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
10.5K
02:57Targeted Cancer Therapies
9.0K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
9.0K
02:34Inhibition of Cdk Activity
6.1K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
6.1K
02:50Combination Therapies and Personalized Medicine
6.3K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
6.3K
01:28Antimicrobial Effectiveness
1.6K
The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...
1.6K